Article Details
Retrieved on: 2023-01-04 07:27:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Chardan Capital upped their target price on PDS Biotechnology from $15.00 to $16.00 and gave the company a buy rating in a research report on Monday, ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here